| Literature DB >> 24360808 |
Karina Tuz1, Ruxandra Bachmann-Gagescu2, Diana R O'Day3, Kiet Hua1, Christine R Isabella3, Ian G Phelps3, Allan E Stolarski1, Brian J O'Roak4, Jennifer C Dempsey3, Charles Lourenco5, Abdulrahman Alswaid6, Carsten G Bönnemann7, Livija Medne8, Sheela Nampoothiri9, Zornitza Stark10, Richard J Leventer11, Meral Topçu12, Ali Cansu13, Sujatha Jagadeesh14, Stephen Done15, Gisele E Ishak15, Ian A Glass16, Jay Shendure17, Stephan C F Neuhauss18, Chad R Haldeman-Englert19, Dan Doherty20, Russell J Ferland21.
Abstract
Joubert syndrome (JBTS) is a recessive ciliopathy in which a subset of affected individuals also have the skeletal dysplasia Jeune asphyxiating thoracic dystrophy (JATD). Here, we have identified biallelic truncating CSPP1 (centrosome and spindle pole associated protein 1) mutations in 19 JBTS-affected individuals, four of whom also have features of JATD. CSPP1 mutations explain ∼5% of JBTS in our cohort, and despite truncating mutations in all affected individuals, the range of phenotypic severity is broad. Morpholino knockdown of cspp1 in zebrafish caused phenotypes reported in other zebrafish models of JBTS (curved body shape, pronephric cysts, and cerebellar abnormalities) and reduced ciliary localization of Arl13b, further supporting loss of CSPP1 function as a cause of JBTS. Fibroblasts from affected individuals with CSPP1 mutations showed reduced numbers of primary cilia and/or short primary cilia, as well as reduced axonemal localization of ciliary proteins ARL13B and adenylyl cyclase III. In summary, CSPP1 mutations are a major cause of the Joubert-Jeune phenotype in humans; however, the mechanism by which these mutations lead to both JBTS and JATD remains unknown.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24360808 PMCID: PMC3882733 DOI: 10.1016/j.ajhg.2013.11.019
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025